FDA Approves Rusfertide in Polycythemia Vera
FDA Approves Rusfertide in Polycythemia Vera CancerNetwork
Regulatory Approvals
This Week at FDA: HHS considering new FDA posts, FDA approves slew of firsts, and more
This Week at FDA: HHS considering new FDA posts, FDA approves slew of firsts, and more RAPS
US FDA approves Takeda, Protagonist’s drug for rare blood cancer
US FDA approves Takeda, Protagonist's drug for rare blood cancer Reuters
Behind the FDA Approval: Daraxonrasib Delivers in Pancreatic Cancer
Behind the FDA Approval: Daraxonrasib Delivers in Pancreatic Cancer Targeted Oncology
FDA Approves Rusfertide for Polycythemia Vera
FDA Approves Rusfertide for Polycythemia Vera OncLive